Risk factors for steroid-refractory in immune checkpoint inhibitor-induced colitis: a retrospective cohort study

BackgroundImmune checkpoint inhibitors (ICIs) represent an effective treatment for various malignant tumors. However, the utilization of ICIs is frequently accompanied by immune-related adverse events (irAEs), among which immune checkpoint inhibitor (ICI)-induced colitis is a notable complication. C...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ke Meng, Jing Chen, Junzhe Chen, Shengjie Sun, Hui Li, Guanzhou Zhou, Fei Pan
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2025-10-01
Col·lecció:Frontiers in Immunology
Matèries:
immune checkpoint inhibitors
steroid refractoriness
immune checkpoint inhibitor-induced colitis
risk factors
interleukin-6
Accés en línia:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623150/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars